Applied dna to resume quarterly investor call cadence beginning with fq3'25 financial results report in mid-august

Stony brook, ny / access newswire / june 16, 2025 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal third quarter 2025 financial results in mid-august 2025. in alignment with this resumption, the company has cancelled its previously scheduled intra-quarter investor call for june 17, 2025.
DNA Ratings Summary
DNA Quant Ranking